Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_assertion type Assertion NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_head.
- NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_assertion description "[Selective BRAF inhibitors have now been established as a standard of care option for patients diagnosed with metastatic melanoma whose tumors carry a BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_provenance.
- NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_assertion evidence source_evidence_literature NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_provenance.
- NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_assertion SIO_000772 23770823 NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_provenance.
- NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_assertion wasDerivedFrom befree-20150227 NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_provenance.
- NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_assertion wasGeneratedBy ECO_0000203 NP272342.RAlUPsAdJBHhEBIb_MndTAQDoYrZkSxFwCIKWv0piJEK4130_provenance.